Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3297512018 | Dolutegravir sodium | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3297665018 | Dolutegravir sodium (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 807041000172112 | dolutégravir sodique | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dolutegravir sodium | Is a | Dolutegravir | false | Inferred relationship | Some | ||
| Dolutegravir sodium | Has disposition (attribute) | Integrase strand transfer inhibitor (disposition) | true | Inferred relationship | Some | ||
| Dolutegravir sodium | Is modification of (attribute) | Dolutegravir | true | Inferred relationship | Some | ||
| Dolutegravir sodium | Is a | Pyrimidine and/or pyrimidine derivative | true | Inferred relationship | Some | ||
| Dolutegravir sodium | Is a | Nucleotidyltransferase inhibitor | false | Inferred relationship | Some | ||
| Dolutegravir sodium | Is a | Integrase strand transfer inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dolutegravir (as dolutegravir sodium) 10 mg oral tablet | Has precise active ingredient | True | Dolutegravir sodium | Inferred relationship | Some | 1 |
| Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dolutegravir sodium | Inferred relationship | Some | 1 |
| Product containing precisely dolutegravir (as dolutegravir sodium) 25 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dolutegravir sodium | Inferred relationship | Some | 1 |
| Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dolutegravir sodium | Inferred relationship | Some | 3 |
This concept is not in any reference sets
FHIR